Medical Device Regulatory Requirements in South Korea

Regulatory Authority Ministry of Food and Drug Safety (MFDS)
Regulatory Authority Website Link Click Here
Device Classification I, II, III, IV
Medical Device Regulations Medical Device Regulation (Same Regulations for IVD) | Click Here
IVD Classification I, II, III, IV
In Vitro Diagnostics Regulations https://www.mfds.go.kr/eng/brd/m_40/list.do
Registration Process Medical Device Registration | Click Here
Registration Timeline 3 to 5 months
Conformity Assessment Route

For Class I medical devices, the process is straightforward. These devices go through an online notification system managed by the National Institute of Medical Device Safety Information (NIDS), and the notification is granted immediately without further review.

For Class II medical devices, the pathway varies based on whether the device is Substantially Equivalent (SE) or Not Substantially Equivalent (NSE) to existing devices. SE devices that conform to predetermined conditions are sent to testing laboratories, which issue a conformity notification, leading to certification within 5 days through NIDS. If the device does not conform to the predetermined conditions or includes modifications, it must be reviewed by a designated review agency, which takes approximately 25 days, after which certification is granted.

Class III and IV medical devices, must undergo a more rigorous evaluation process under MFDS. This includes a Technical Document Review, which takes approximately 65 days, and a Clinical Data Review, which may take up to 80 days. Following these evaluations, the device is considered for final approval. This tiered, scientifically grounded system ensures that the regulatory scrutiny matches the level of risk posed by the medical device, facilitating a predictable and structured approval process.

| Click Here
Technical Documentation Format
  • The technical documents is consist of ‘Application Form’ and ‘Supplementary Evidence’. The presence of mandatory submission of ‘clinical trial reports’(as a part of ‘Supplementary Evidence’) determines application procedure to be followed.

 

  • 2.1 General Technical Document Review
    • If a device is substantially equivalent legally marketed devices, ‘clinical trial reports’ are not required.

 

  • 2.2 Safety and Efficacy Review(SER)
    • The technical document including ‘clinical tiral reports’ is thoroughly reviewed
      ‘Clinical trial reports’ are required if differences such as ‘Intended Use’, ‘Mechanism of Action(MoA)’ and ‘Raw Materials’ could significantly affect safety and efficacy of devices
Requirement of Authorized Representative YES
Language Requirement Labels must be in Korean Language
Labeling Requirements

Regulations on Labeling and Description of Medical Devices

| Click Here
Recalls

(Firm-initiated Recall) Recall made usually voluntarily by the firm after the discovery of safety issues or product defects that may have potential health risk to patients.


(Government-initiated Recall) Recall order made by Minister of MFDS when the product is determined to be defective or potentially harmful.

| Click Here
Advertising and Promotions

Regulation on Prior Review of Advertisement on Medical Device

| Click Here
Additional Information

MFDS Quality Management System (QMS) regulations are made based on ISO 13485.


All medical device manufacturers required to comply with QMS regulations if their devices are distributed in Korea


On-site audits are mandatory for class 2, 3, and 4 devices manufacturers, but it is elective for class 1 device manufacturers

Disclaimer: This website sources information from regulatory authorities and aims for accuracy, but regulations may change without notice. Users are advised to verify details with relevant authorities before making compliance decisions. We are not responsible for errors, omissions, or outdated content.

The above information is last updated on 03/May/2025

If you found this helpful, consider supporting by buying me a coffee ☕
Every little bit counts!